au.\*:("SALVESEN, H")
Results 1 to 25 of 32
Selection :
The Hoset project. An interdisciplinary study of a marginal settlementSALVESEN H; SANDNES J; FARBREGD O et al.Norvegian Archaeological Review. 1977, Vol 10, Num 1-2, pp 107-154Article
Non-reflecting boundary conditions applicable to general purpose CFD simulatorsSALVESEN, H.-C; TEIGLAND, R.International journal for numerical methods in fluids. 1998, Vol 28, Num 3, pp 523-540, issn 0271-2091Article
Perforated peptic ulcer over 56 years. Time trends in patients and disease characteristicsSVANES, C; SALVESEN, H; STANGELAND, L et al.Gut. 1993, Vol 34, Num 12, pp 1666-1671, issn 0017-5749Article
Intact serum parathyroid hormone levels increase during running exercise in well-trained menSALVESEN, H; JOHANSSON, A. G; FOXDAL, P et al.Calcified tissue international. 1994, Vol 54, Num 4, pp 256-261, issn 0171-967XConference Paper
Prognostic impact of EGF-receptor in papillary thyroid carcinomaAKSLEN, L. A; MYKING, A. O; SALVESEN, H et al.British journal of cancer. 1993, Vol 68, Num 4, pp 808-812, issn 0007-0920Article
Trends in and value and consequences of radiologic imaging of perforated gastroduodenal ulcer: a 50-year experienceSVANES, C; SALVESEN, H; LARSSEN, T. B et al.Scandinavian journal of gastroenterology. 1990, Vol 25, Num 3, pp 257-262, issn 0036-5521Article
A multicfactorial analysis of factors related to lethality after treatment of perforated gastroduodenal ulcer: 1935-1985SVANES, C; SALVESEN, H; ESPEHAUG, B et al.Annals of surgery. 1989, Vol 209, Num 4, pp 418-423, issn 0003-4932Article
Change in levels of the carboxyterminal propeptide of type I procollagen, the carboxyterminal cross-linked telopeptide of type I collagen and osteocalcin in response to exercise in well-trained men and womenSALVESEN, H; PIEHL-AULIN, K; LJUNGHALL, S et al.Scandinavian journal of medicine & science in sports. 1994, Vol 4, Num 3, pp 186-190, issn 0905-7188Article
Prognostic importance of various clinicopathological features in papillary thyroid carcinomaAKSLEN, L. A; MYKING, A. O; SALVESEN, H et al.European journal of cancer. Part A. 1993, Vol 29, Num 1, pp 44-51Article
Thyroid carcinoma : results from surgical treatment in 211 consecutive patientsSALVESEN, H; NJØLSTAD, P. R; AKSLEN, L. A et al.Acta chirurgica. The european journal of surgery. 1991, Vol 157, Num 9, pp 521-526Article
The Hoset Project. An Interdisciplinary Study of a Marginal SettlementSALVESEN, H; SANDNES, J; FARBREGD, O et al.Norwegian Archaeological Review Oslo. 1977, Vol 10, Num 1-2, pp 107-154Article
Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomasSALVESEN, H. B; AKSLEN, L. A.International journal of cancer. 1999, Vol 84, Num 5, pp 539-543, issn 0020-7136Article
Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosisSALVESEN, H. B; DAS, S; AKSLEN, L. A et al.Clinical cancer research. 2000, Vol 6, Num 1, pp 153-159, issn 1078-0432Article
Angiogenesis is prognostically important in vertical growth phase melanomasSTRAUME, O; SALVESEN, H. B; AKSLEN, L. A et al.International journal of oncology. 1999, Vol 15, Num 3, pp 595-599, issn 1019-6439Article
Staging of endometrial carcinomas with MRI using traditional and novel MRI techniquesHALDORSEN, I. S; SALVESEN, H. B.Clinical radiology. 2012, Vol 67, Num 1, pp 2-12, issn 0009-9260, 11 p.Article
Independent prognostic importance of microvessel density in endometrial carcinomaSALVESEN, H. B; IVERSEN, O. E; AKSLEN, L. A et al.British journal of cancer. 1998, Vol 77, Num 7, pp 1140-1144, issn 0007-0920Article
Prognostic impact of morphometric nuclear grade of endometrial carcinomaSALVESEN, H. B; IVERSEN, O. E; AKSLEN, L. A et al.Cancer. 1998, Vol 83, Num 5, pp 956-964, issn 0008-543XArticle
Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression : A population-based endometrial carcinoma studySALVESEN, H. B; IVERSEN, O. E; AKSLEN, L. A et al.Journal of clinical oncology. 1999, Vol 17, Num 5, pp 1382-1390, issn 0732-183XArticle
Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomasSALVESEN, H. B; IVERSEN, O. E; AKSLEN, L. A et al.Clinical cancer research. 1998, Vol 4, Num 11, pp 2779-2785, issn 1078-0432Article
Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid typeSTEFANSSON, I. M; SALVESEN, H. B; IMMERVOLL, H et al.Histopathology. 2004, Vol 44, Num 5, pp 472-479, issn 0309-0167, 8 p.Article
Poorer survival of nulliparous women with endometrial carcinomaSALVESEN, H. B; AKSLEN, L. A; ALBREKTSEN, G et al.Cancer. 1998, Vol 82, Num 7, pp 1328-1333, issn 0008-543XArticle
Recurrence of endometrial carcinoma and the value of routine follow upSALVESEN, H. B; AKSLEN, L. A; IVERSEN, T et al.British journal of obstetrics and gynaecology (Print). 1997, Vol 104, Num 11, pp 1302-1307, issn 0306-5456Article
Diagnostic screening of NEUROD1 (MODY6) in subjects with MODY or gestational diabetes mellitusSAGEN, J. V; BAUMANN, M. E; SALVESEN, H. B et al.Diabetic medicine. 2005, Vol 22, Num 8, pp 1012-1015, issn 0742-3071, 4 p.Article
Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomasMACDONALD, N. D; SALVESEN, H. B; RYAN, A et al.Cancer research (Baltimore). 2000, Vol 60, Num 6, pp 1750-1752, issn 0008-5472Article
High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitorsENGERUD, H; TANGEN, I. L; KRAKSTAD, C et al.British journal of cancer. 2014, Vol 111, Num 1, pp 78-84, issn 0007-0920, 7 p.Article